BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33414554)

  • 1. Neurological infection with SARS-CoV-2 - the story so far.
    Solomon T
    Nat Rev Neurol; 2021 Feb; 17(2):65-66. PubMed ID: 33414554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SARS-CoV-2 and neurological disorders: the revelance of biomarkers?].
    Bigot-Corbel E; Lanore A; Raulet C; Delorme C; Azulay JP; Lehmann S; Beaudeux JL; Beauvieux MC; Sapin V; Peoc'h K; Rucheton B;
    Ann Biol Clin (Paris); 2021 Feb; 79(1):7-16. PubMed ID: 33570039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms.
    Neumann B; Schmidbauer ML; Dimitriadis K; Otto S; Knier B; Niesen WD; Hosp JA; Günther A; Lindemann S; Nagy G; Steinberg T; Linker RA; Hemmer B; Bösel J;
    J Neurol Sci; 2020 Nov; 418():117090. PubMed ID: 32805440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological complications of a SARS-CoV-2 infection require a thorough and comprehensive evaluation.
    Finsterer J
    Eur J Pediatr; 2024 Jun; 183(6):2811-2812. PubMed ID: 38492033
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurological Symptoms of COVID-19: The Zonulin Hypothesis.
    Llorens S; Nava E; Muñoz-López M; Sánchez-Larsen Á; Segura T
    Front Immunol; 2021; 12():665300. PubMed ID: 33981312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neurological impact of COVID-19.
    The Lancet Neurology
    Lancet Neurol; 2020 Jun; 19(6):471. PubMed ID: 32470408
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurological complications of COVID-19: from bridesmaid to bride.
    Nath A; Smith B
    Arq Neuropsiquiatr; 2020 Sep; 78(8):459-460. PubMed ID: 32901698
    [No Abstract]   [Full Text] [Related]  

  • 9. Update on the neurology of COVID-19.
    Finsterer J; Stollberger C
    J Med Virol; 2020 Nov; 92(11):2316-2318. PubMed ID: 32401352
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders.
    Amruta N; Chastain WH; Paz M; Solch RJ; Murray-Brown IC; Befeler JB; Gressett TE; Longo MT; Engler-Chiurazzi EB; Bix G
    Cytokine Growth Factor Rev; 2021 Apr; 58():1-15. PubMed ID: 33674185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019.
    Yin R; Feng W; Wang T; Chen G; Wu T; Chen D; Lv T; Xiang D
    J Med Virol; 2020 Oct; 92(10):1782-1784. PubMed ID: 32293714
    [No Abstract]   [Full Text] [Related]  

  • 12. Community-Acquired Neonatal SARS-CoV-2 Infection Associated with Neurological Symptoms in Colombia.
    Alvarado-Socarras JL; Theurel-Martin D; Cruz-Hernandez M; Rodriguez-Morales AJ
    J Trop Pediatr; 2021 Jan; 67(1):. PubMed ID: 33823049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological involvement of COVID-19: from neuroinvasion and neuroimmune crosstalk to long-term consequences.
    Septyaningtrias DE; Susilowati R
    Rev Neurosci; 2021 Jun; 32(4):427-442. PubMed ID: 33550780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [COVID-19: A neurological point-of-view].
    Simon OJ; Timmermann L
    Dtsch Med Wochenschr; 2020 Jul; 145(15):1074-1079. PubMed ID: 32731282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological manifestations in 404 COVID-19 patients in Washington State.
    Agarwal P; Ray S; Madan A; Tyson B
    J Neurol; 2021 Mar; 268(3):770-772. PubMed ID: 32761507
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurological Complications in COVID-19 Patients and its Implications for Associated Mortality.
    AboTaleb HA
    Curr Neurovasc Res; 2020; 17(4):522-530. PubMed ID: 32718292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does COVID-19 contribute to development of neurological disease?
    Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
    Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial Injury in Adults Hospitalized With COVID-19.
    Smilowitz NR; Jethani N; Chen J; Aphinyanaphongs Y; Zhang R; Dogra S; Alviar CL; Keller N; Razzouk L; Quinones-Camacho A; Jung AS; Fishman GI; Hochman JS; Berger JS
    Circulation; 2020 Dec; 142(24):2393-2395. PubMed ID: 33151762
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].
    Bereczki D; Stang R; Böjti P; Kovács T
    Ideggyogy Sz; 2020 May; 73(05-06):171-175. PubMed ID: 32579306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long COVID: understanding the neurological effects.
    The Lancet Neurology
    Lancet Neurol; 2021 Apr; 20(4):247. PubMed ID: 33743226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.